13F

Stock

Dare Bioscience, Inc.

DARE · held by 27 managers

Reported value

$1.83M

Holders

27

+0 new · −0 exited

Holders’ est. mark

−$21

Price effect on 1 books still in the name

Largest holder

$1.01M

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard523.1K$1.01MHeld
GEODE CAPITAL MANAGEMENT, LLC118.7K$229KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP70K$135.1KHeld
TWO SIGMA INVESTMENTS, LP33K$63.8KHeld
State Street23.5K$45.4KHeld
US BANCORP \DE\20.9K$40.4KHeld
UBS Group AG20.9K$40.4KHeld
Renaissance Technologies19.3K$37.2KHeld
TWO SIGMA ADVISERS, LP17.9K$34.5KHeld
BlackRock, Inc.17K$32.8KHeld
NORTHERN TRUST CORP15.4K$29.8KHeld
RAYMOND JAMES FINANCIAL INC15.3K$29.6KHeld
LPL Financial LLC14.6K$28.3KHeld
XTX Topco Ltd11K$21.2KHeld
Objectivity Squared, LLC10.9K$21.1KHeld
JANE STREET GROUP, LLC10.6K$20.4KHeld
Parallel Advisors, LLC2.4K$4.64KHeld
IFS Advisors, LLC950$1.83KHeld
SBI Securities Co., Ltd.575$1.11KHeld
BANK OF AMERICA CORP /DE/129$250−$21Cut−$25
Tower Research Capital LLC (TRC)110$212Held
Virtu Financial LLC19.2K$37Held
CALDWELL SUTTER CAPITAL, INC.17$33Held
Inspire Investing, LLC12$23Held
PRICE T ROWE ASSOCIATES INC /MD/10.2K$20Held
HRT FINANCIAL LP10.5K$20Held
Cornerstone Planning Group LLC2$4Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.